HemaSphere (Aug 2023)
P1138: FIVE-YEAR EFFICACY AND SAFETY OF TAFASITAMAB IN PATIENTS WITH RELAPSED OR REFRACTORY DLBCL: FINAL RESULTS FROM THE PHASE II L-MIND STUDY
- Johannes Duell,
- Pau Abrisqueta,
- Marc Andre,
- Marinela Augustin,
- Gianluca Gaidano,
- Eva González Barca,
- Wojciech Jurczak,
- Nagesh Kalakonda,
- Anna Marina Liberati,
- Kami Maddocks,
- Tobias Menne,
- Zsolt Nagy,
- Olivier Tournilhac,
- Abhishek Bakuli,
- Aasim Amin,
- Konstantin Gurbanov,
- Gilles Salles
Affiliations
- Johannes Duell
- 1 Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany
- Pau Abrisqueta
- 2 Department of Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron University Hospital, Barcelona, Spain
- Marc Andre
- 3 CHU UCL Namur, Department of Hematology, Yvoir, Belgium
- Marinela Augustin
- 4 Klinikum Nuernberg, Paracelsus Medical University, Clinical Trial Unit, Department of Hematology and Oncology, Nuernberg, Germany
- Gianluca Gaidano
- 5 Amedeo Avogadro University of Eastern Piedmont, Division of Hematology, Department of Translational Medicine & IRCAD, Novara, Italy
- Eva González Barca
- 6 Institut Català d’Oncologia, Barcelona University, Barcelona, Spain
- Wojciech Jurczak
- 7 Maria Sklodowska-Curie National Research Institute of Oncology, Kraków, Poland
- Nagesh Kalakonda
- 8 University of Liverpool, Liverpool, United Kingdom
- Anna Marina Liberati
- 9 Università degli Studi di Perugia, Terni, Italy
- Kami Maddocks
- 10 Department of Internal Medicine, Arthur G James Comprehensive Cancer Center, Ohio State University Wexner Medical Center, Ohio, United States
- Tobias Menne
- 11 Freeman Hospital, The Newcastle upon Tyne Hospitals, NHS Foundation Trust, Tyne, United Kingdom
- Zsolt Nagy
- 12 Semmelweis University, Budapest, Hungary
- Olivier Tournilhac
- 13 CHU de Clermont-Ferrand, Lyon, United Kingdom
- Abhishek Bakuli
- 14 MorphoSys AG, Planegg, Germany
- Aasim Amin
- 14 MorphoSys AG, Planegg, Germany
- Konstantin Gurbanov
- 14 MorphoSys AG, Planegg, Germany
- Gilles Salles
- 15 Memorial Sloan Kettering Cancer Center, New York, United States
- DOI
- https://doi.org/10.1097/01.HS9.0000971448.45809.41
- Journal volume & issue
-
Vol. 7
p. e4580941
Abstract
No abstracts available.